CVS Health Corporation (NYSE: CVS) shares closed slightly higher on Wednesday. JPMorgan analyst Lisa Gill maintained an Overweight rating but lowered the price target from $101 to $86. Baird analyst Michael Ha initiated coverage with a Neutral rating and a price target of $61. CVS Health reported Q1 sales of $88.4 billion, missing the consensus of $89.21 billion, and lowered its 2024 adjusted EPS guidance. The company has a dividend yield of 4.38%, translating to a quarterly dividend of 66.5 cents per share. To earn $500 monthly from CVS dividends, an investor would need approximately 2,256 shares, worth around $136,939.